张真庆，男，苏州大学特聘教授，江苏特聘教授，以糖类药物为研究对象先后在Nat.Biotech, PNAS，JACS，NPR，JBC, Anal. Chem.，JMC等杂志发表论文50余篇。总影响因子超过了190，截止到2012年总引次数超过了700。申请美国专利两项。 张真庆博士在糖化学糖生物学以及糖类药物的分析与开发领域获得了广泛的认可，有较高的知名度。
1996.09 - 2000.06：中国海洋大学，药学；2000.09 - 2006.06：中国海洋大学，工学博士，研究方向糖科学；2006.08 - 2009.09：美国Rensselaer Polytechnic Institute, 博士后；2009.10 –2012.08：美国Baxter Healthcare,研究员；2012.08 – ：苏州大学药学院，教授。
1、肝素及肝素类药物的分析，鉴定2、糖蛋白和蛋白聚糖的糖基化分析3、活性糖链的生物合成、衍生以及蛋白的多糖修饰研究4、活性糖链与抗肿瘤和抗神经退行性疾病的构效关系研究5、糖类药物的研究与开发
张真庆教授以糖类药物为研究对象先后在, 等杂志发表论文50余篇。总影响因子超过了190，截止到2012年总引次数超过了700。申请美国专利两项。 张真庆博士在糖化学糖生物学以及糖类药物的分析与开发领域获得了广泛的认可，有较高的知名度。1. M. Guerrini, D. Beccati, Z. Shriver, A. Naggi, K. Viswanathan, A. Bisio, I. Capila, J.C. Lansing, S. Guglieri, B. Fraser, A. Al-Hakim, N.S. Gunay,, L. Robinson, L. Buhse, M. Nasr, J. Woodcock, R. Langer, G. Venkataraman, R.J. Linhardt, B. Casu, G. Torri, R. Sasisekharan*. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events, , 2008, 26(6): 669-675. 2. M. Guerrini,, Z. Shriver, A. Naggi , S. Masuko , R. Langer, B. Casu , R. J. Linhardt , G. Torri, R. Sasisekharan*, Orthogonal analytical approaches to detect potential contaminants in heparin, , 2009, 106, 16956-61.  3. , S.A. McCallum, J. Xie, L. Nieto, F. Corzana, J. Jiménez-Barbero, M. Chen, J. Liu, R.J. Linhardt*. Solution Structures of Chemoenzymatically Synthesized Heparin and Its Precursors, , 2008, 130(39): 12998-3007.4. H. Liu, , R.J. Linhardt*. Lessons learned from the contamination of heparin,  (), highlight paper, 2009, 26(3):313-321.5. , N. Khan, C.M. Szabo, Complete Monosaccharide Analysis by High Performance Anion Exchange Chromatography with Pulsed Amperometric Detection. 2012, 84, 4104-4110. 6. , J. Xie, H. Liu, J. Liu, R.J. Linhardt*. Quantitification of Heparan Sulfate Disaccharides Using Ion-pairing, Reverse-Phase, Micro-flow, High Performance Liquid Chromatography with Electrospray Ionization Trap Mass Spectrometry. 2009, 81, 4349-4355. 7. , M. Weïwer, B. Li, M.M. Kemp, T.H. Daman, R.J. Linhardt*. Oversulfated Chondroitin Sulfate: Impact of a Heparin Impurity, Associated with Adverse Clinical Events, on Low-Molecular-Weight Heparin Preparation. , 2008, 51(18): 5498-501. 8.  J. Xie, J. Liu, R.J. Linhardt*. Tandem MS can distinguish hyaluronic acid from N-acetylheparosan, , 2008, 19(1): 82-90. 9. , G. Yu, X Zhao, H. Liu, H Guan, A.M. Lawson W. Chai*. Sequence analysis of alginate-derived oligosaccharide by ESI/CID-MS/MS. 2006, 17, 621–630. “ SCI ” 10. , J. Xie, F. Zhang, R.J. Linhardt*. Thin-layer chromatography for the analysis of glycosaminoglycan oligosaccharides. , 2007, 371(1): 118-120. “ SCI ” 11.  Y. Park, M.M. Kemp, W. Zhao, D. Shaya, M. Cygler, Y.S. Kim, R.J. Linhardt*.Liquid chromatography–mass spectrometry to study chondroitin lyase action pattern, 2009, 385(1): 57-64. 12. , B. Li, J. Suwan, F. Zhang, R.J. Linhardt*. Analysis of pharmaceutical heparins and potential contaminants using H-NMR and PAGE, , 2009, 98(11):4017-4026. 13. , R.J. Linhardt*. Sequence analysis of native oligosaccharides using negative ESI tandem MS, , 2009, 5, 225-237. 14.  G. Yu*, H. Guan, X. Zhao, Y. Du, X. Jiang, Preparation and structure elucidation of alginate oligosaccharides degraded by alginate lyase from 510. 2004, 399,1475-1481.15. , Z. Xiao, R.J. Linhardt*. Thin Layer Chromatography for the Separation and Analysis of Acidic Carbohydrates, 2009, 1711-1732. 16. Z. Wang, B. Yang, , M. Ly, M. Takieddin, S. Mousa, J. Liu, J. S. Dordick, R.J. Linhardt* Control of the heparosan -1 deacetylation leads to animproved bioengineered heparin. 2011,91-99. 17. G. Yu, Y. Zhang, , L. Song, W. Chai*, The Effect and Limitation of Excess Ammonium on the Release of -Glycansin Reducing Forms from Glycoproteins under Mild Alkaline Conditions for Glycomic and Functional Analysis. , 2010, 82, 9534-9542. 18. T. N. Laremore, M. Ly, , K. Solakyildirim, S. McCallum, R. T. Owens, R. J. Linhardt*, LC-MS disaccharide composition analysis for the domain structure elucidation of decorin glycosaminoglycan. , 2010, 431:199-205. 19. Z. Xiao, W. Zhao, B. Yang, , H. Guan, R. J. Linhardt*, HeparinaseⅠ susceptible 3,6-di-O-sulfo-2-deoxy-2- sulfamido- a-D-glucopyranose (1,4) 2-O-sulfo- a-L-idopyranosyluronic acid linkage. , 2011, 21: 13-22. “ SCI ” 20. D. Shaya, W. Zhao, M.L. Garron, Z. Xiao, Q. Cui,  T. Sulea, R.J. Linhardt, M. Cygler, Catalytic mechanism of heparinase II investigated by site-directed mutagenesis and the crystal structure with its substrate. 2010, 25; 285(26):20051-61. 21. Z. Wang, , SA McCallum, RJ Linhardt*, Nuclear magnetic resonance quantification for monitoring heparosan K5 capsular polysaccharide production. , 2010, 398, 275-277. 22. AR Im, Y Park, JS Sim, , Z. Liu, RJ Linhardt, YS Kim*, Glycosaminoglycans from earthworms (Eiseniaandrei). “ SCI ”  27(2):249-257. 23. K. Solakyildirim,, R. Linhardt*, Ultraperformance Liquid Chromatography with Electrospray Ion Trap Mass Spectrometry for Chondroitin Disaccharide Analysis. 2010397: 24-28.24. S. Bhattacharyya, K. Solakyildirim, , R. J. Linhardt, J. K. Tobacman*. Increase in Cell-Bound Interleukin-8 follows Silencing of N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) and is Attributable to Increased Chondroitin 4-Sulfate. 2010, 42, 51-61. 25. S. Bhattacharyya, H. Liu, , G. Michel, R. J. Linhardt, J. Tobacman*. Carrageenan-Induced Innate Immune Response is Modified by Enzymes that Hydrolyze Distinct Galactosidic Bonds. 201021, 906–913.26. S. Bhattacharyya, K. Solakyildirim, , R.J. Linhardt, J.K. Tobacman*. Chloroquine reduces arylsulphatase B activity and increases chondroitin-4-sulphate: implications for mechanisms of action and resistance. 2009，8，303 8(1):303. 27. Y. Han, M. Garron, H. Kim, W. Kim,  K. Ryu, D. Shaya, Z. Xiao, C. Cheong, Y. Kim, R. Linhardt, M. Cygler*, Structural snapshots of heparin depolymerization by heparin lyase I. 2009, 284: 34019-34027.28. F. Zhang, , X. Lin, A. Beenken, M. Mohammadi, R. J. Linhardt*, Compositional analysis on heparin/heparan sulfate interacting with FGF·FGFR complexes. , 2009, 48, 8379–8386.29. B. Li, J. Suwan, J. G. Martin, F.Zhang, , D. Hoppensteadt, M. Clark, J. Fareed, R. J. Linhardt* Oversulfated chondroitin sulfate interaction with heparin-binding proteins: New insights into adverse reactions from contaminated heparins, 2009, 72, 292-300. 30. J. Suwan, , B. Li, P. Vongchan, P. Meepowpan, F.Zhang, S. A. Mousa, S. Mousa, B. Premanode, P. Kongtawelert, R. J. Linhardt*. Sulfonation of papain treated chitosan and its mechanism for anticoagulant activity.  2009, 344, 1190-1196.31. N. Volpi*, , R.J. Linhardt. Mass spectrometry for the characterization of unsulfated chondroitin oligosaccharides from 2-mers to 16-mers. Comparison with hyaluronic acid oligomers. , 2008, 22(22): 3526-30. 32. F. Zhang, , R. Thistle, L. McKeen, S. Hosoyama, T. Toida, R.J. Linhardt*, P. Page-McCaw. Structural characterization of glycosaminoglycans from zebrafish in different ages. , 2009, 26(2):211-218. 33. Y. Park, , R.J. Linhardt, E.K. Lemosy*. Distinct heparan sulfate compositions in wild-type and pipe-mutant eggshell matrix. , 2008, 2, 175 – 179. 34. Y. Park,, T.N. Laremore, B. Li, J.S. Sim, A.R. Im, M.Y. Ahn, Y.S. Kim, R.J. Linhardt*. Variation of acharan sulfate and monosaccharide composition and analysis of neutral N-glycans in African giant snail (). , 2008, 25(9): 863-877. 35. A.I. de Agostini*, J.C. Dong, C. de VantéryArrighi, M.A. Ramus, I. Dentand-Quadri, S. Thalmann, P. Ventura, V. Ibecheole, F. Monge, A.M. Fischer, S. Hajmohammadi, N.W. Shworak, L. Zhang, , R.J. Linhardt. Human follicular fluid heparan sulfate contains abundant 3--sufated chains with anticoagulant activity.  2008, 283(42): 28115-24. 36. M. Warda, F. Zhang, M. Radwan, , N. Kim, Y.N. Kim, R.J. Linhardt, J. Han*. Is human placenta proteoglycan remodeling involved in pre-eclampsia? , 2008, 25(5): 441-450. 37. A. Silipo, , F.J. Cañada, A. Molinaro, R.J. Linhardt, J. Jiménez-Barbero*. Conformational analysis of a dermatan sulfate-derived tetrasaccharide by NMR, molecular modeling, and residual dipolar couplings. 2008, 9(2):240-252. 38. X. Zhao*, G. Yu, H. Guan, N. Yue, , H. Li. Preparation of low-molecular-weight polyguluronate sulfate and its anticoagulant and anti-inflammatory activities. ,2007, 69(2): 272-279.39. L. Gan, X. Xin, J. Li, H. Liu,  J. Qian, J. Ding, M. Geng*. Characterization of Conformational Epitope of Alginate-derived Poly- mannuronates by Surface Plasmon Resonance. 2005 87, 959-66. 40. H. Liu, M. Geng, X. Xin, F. Li,  J. Li, J. Ding*. Multiple and Multivalent Interactions of Novel Anti-AIDS Drug Candidates, Sulfated Polymannuronate (SPMG)-derived Oligosaccharides, with gp120, and their Anti-HIV Activities.2005, 15, 501-510. 41. F. Zhang, , R. Linhardt*,Glycosaminoglycans, in Handbook of Glycomics: Glycoconjugate Structural Analysis, R.D. Cummings, M. Pierce (eds.) Academic Press/Elsevier, 2009, Chapter 3, 59-80.42. B. Li, H. Liu, , H. Stansfield, J. Dordick, R. Linhardt*. Analysis of glycosaminoglycans in stem cell glycomics. in Embryonic Stem Cell Therapy for Osteodegenerative Diseases. Nicole zur Nieden, Ed., Humana Press, Methods in Molecular Biology 2011, 690, 285-300.主要论文1. M. Guerrini, D. Beccati, Z. Shriver, A. Naggi, K. Viswanathan, A. Bisio, I. Capila, J.C. Lansing, S. Guglieri, B. Fraser, A. Al-Hakim, N.S. Gunay, Z. Zhang, L. Robinson, L. Buhse, M. Nasr, J. Woodcock, R. Langer, G. Venkataraman, R.J. Linhardt, B. Casu, G. Torri, R. Sasisekharan*. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events, , 2008, 26(6): 669-675. 影响因子312. M. Guerrini,Z. Zhang, Z. Shriver, A. Naggi , S. Masuko , R. Langer, B. Casu , R. J. Linhardt , G. Torri, R. Sasisekharan*, Orthogonal analytical approaches to detect potential contaminants in heparin, , 2009, 106, 16956-61. Co- first authors. 影响因子9.83. Z. Zhang, S.A. McCallum, J. Xie, L. Nieto, F. Corzana, J. Jiménez-Barbero, M. Chen, J. Liu, R.J. Linhardt*. Solution Structures of Chemoenzymatically Synthesized Heparin and Its Precursors, , 2008, 130(39): 12998-3007.影响因子9.04. H. Liu, Z. Zhang, R.J. Linhardt*. Lessons learned from the contamination of heparin,  (), highlight paper, 2009, 26(3):313-321.影响因子7.75. Z. Zhang*, N. Khan, C.M. Szabo, Complete Monosaccharide Analysis by High Performance Anion Exchange Chromatography with Pulsed Amperometric Detection. 2012, 84, 4104-4110. 影响因子5.86. Z. Zhang, J. Xie, H. Liu, J. Liu, R.J. Linhardt*. Quantitification of Heparan Sulfate Disaccharides Using Ion-pairing, Reverse-Phase, Micro-flow, High Performance Liquid Chromatography with Electrospray Ionization Trap Mass Spectrometry. 2009, 81, 4349-4355. 影响因子5.87. Z. Zhang, M. Weïwer, B. Li, M.M. Kemp, T.H. Daman, R.J. Linhardt*. Oversulfated Chondroitin Sulfate: Impact of a Heparin Impurity, Associated with Adverse Clinical Events, on Low-Molecular-Weight Heparin Preparation. , 2008, 51(18): 5498-501. 影响因子5.28. Z. Zhang, J. Xie, J. Liu, R.J. Linhardt*. Tandem MS can distinguish hyaluronic acid from N-acetylheparosan, , 2008, 19(1): 82-90. 影响因子3.89. Z. Zhang, G. Yu, X Zhao, H. Liu, H Guan, A.M. Lawson W. Chai*. Sequence analysis of alginate-derived oligosaccharide by ESI/CID-MS/MS. 2006, 17, 621–630. “ SCI ” 影响因子3.810. Z. Zhang, J. Xie, F. Zhang, R.J. Linhardt*. Thin-layer chromatography for the analysis of glycosaminoglycan oligosaccharides. , 2007, 371(1): 118-120. “ SCI ” 影响因子3.3
    